%0 Journal Article
%T Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease
%A Hai M. Nguyen
%A Heike Wulff
%A Jacopo Di Lucente
%A Latika Singh
%A Lee©\Way Jin
%A Monique Chavez
%A Trevor Bushong
%A Vikrant Singh
%J Archive of "Annals of Clinical and Translational Neurology".
%D 2019
%R 10.1002/acn3.754
%X Microglia play a pivotal role in the initiation and progression of Alzheimer's disease (AD). We here tested the therapeutic hypothesis that the Ca2+©\activated potassium channel KCa3.1 constitutes a potential target for treating AD by reducing neuroinflammation
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469250/